CERA

Science and Research

Polyactiva (1b): An open label, comparative, sequential-dose, multi-centre study involving intracameral administration of a PA5108 Latanoprost FA SR Ocular Implant into the eye of patients with mild-moderate glaucoma.

Overview

  • Principal Investigator
Professor Keith Martin